AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Laparoscopic Ultrasound Versus Fluorescence Cholangiography in Technically Challenging Laparoscopic Cholecystectomy

RecruitingNAAges 18 Years - anyAllConsorci Sanitari Integral
💬

In plain words

What the trial is, and whether it could suit you

This is a multicenter, prospective, interventional clinical trial designed to evaluate and compare two intraoperative imaging modalities: laparoscopic ultrasound (LUS) and fluorescence cholangiography with indocyanine green (ICG), for the identification of biliary anatomy in technically challenging laparoscopic cholecystectomy. All enrolled subjects will undergo both LUS and ICG during the index procedure, following a standardized sequence, in order to allow intra-subject comparison. LUS will be performed first, followed by fluorescence cholangiography prior to Calot's triangle dissection. The primary endpoint is the successful identification of the critical junction. Secondary endpoints include visualization of individual biliary structures, time to visualization, total operative time, intraoperative and postoperative complications.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age ≥ 18 years. 2. Written informed consent provided. 3. Indication for laparoscopic cholecystectomy with anticipated technical difficulty due to one or more of the following: * Acute cholecystitis. * Previous cholangitis, pancreatitis, or endoscopic retrograde cholangiopancreatography. * Prior upper abdominal surgery. * Obesity (Body Mass Index ≥ 30 kg/m²). Exclusion Criteria: 1. Known allergy to ICG or iodine. 2. Pregnancy or breastfeeding. 3. High risk of choledocholithiasis (ESGE guidelines). 4. Thyroid disease. 5. Suspected gallbladder malignancy. 6. ASA class IV-V. 7. Chronic kidney disease stage \> IIIb. 8. Planned open cholecystectomy.
💊

What it tests

  • Laparoscopic ultrasound (LUS) and fluorescence cholangiography with indocyanine green (ICG)
📍

Where

1 site
Complex Hospitalari Universitari Moisès Broggi, Consorci Sanitari Integral
Sant Joan Despí, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy